28-Jan-2026
Download PDF
Onesource Specialty Pharma
Disclosure under Regulation 29(2) of SEBI (SAST) Regulations 2011 and Regulation 7(2) of SEBI (PIT) Regulations 2015. Promoter entity (Tenshi Pharmaceuticals Private Limited) has purchased 2 00 000 equity shares of the Company from the market on January 28 2026.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
Widely read:
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
